These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28815548)

  • 1. Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.
    Mørch RH; Dieset I; Faerden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Haram M; Falk RS; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Acta Psychiatr Scand; 2017 Oct; 136(4):400-408. PubMed ID: 28815548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory evidence for the psychosis continuum model.
    Mørch RH; Dieset I; Færden A; Hope S; Aas M; Nerhus M; Gardsjord ES; Joa I; Morken G; Agartz I; Aukrust P; Djurovic S; Melle I; Ueland T; Andreassen OA
    Psychoneuroendocrinology; 2016 May; 67():189-97. PubMed ID: 26923849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
    Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.
    Hope S; Hoseth E; Dieset I; Mørch RH; Aas M; Aukrust P; Djurovic S; Melle I; Ueland T; Agartz I; Ueland T; Westlye LT; Andreassen OA
    Schizophr Res; 2015 Jul; 165(2-3):188-94. PubMed ID: 25956633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders.
    Gohar SM; Dieset I; Steen NE; Mørch RH; Iversen TS; Steen VM; Andreassen OA; Melle I
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):795-802. PubMed ID: 29721726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.
    Tsai SY; Chung KH; Wu JY; Kuo CJ; Lee HC; Huang SH
    J Affect Disord; 2012 Jan; 136(1-2):110-116. PubMed ID: 21962564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between altered brain morphology and elevated peripheral endothelial markers--implications for psychotic disorders.
    Dieset I; Haukvik UK; Melle I; Røssberg JI; Ueland T; Hope S; Dale AM; Djurovic S; Aukrust P; Agartz I; Andreassen OA
    Schizophr Res; 2015 Feb; 161(2-3):222-8. PubMed ID: 25433965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls.
    Hoseth EZ; Westlye LT; Hope S; Dieset I; Aukrust P; Melle I; Haukvik UK; Agartz I; Ueland T; Ueland T; Andreassen OA
    Acta Psychiatr Scand; 2016 Jan; 133(1):53-62. PubMed ID: 26189721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.
    Bai YM; Su TP; Tsai SJ; Wen-Fei C; Li CT; Pei-Chi T; Mu-Hong C
    J Affect Disord; 2014 Sep; 166():187-92. PubMed ID: 25012430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study.
    Sveaas SH; Berg IJ; Provan SA; Semb AG; Olsen IC; Ueland T; Aukrust P; Vøllestad N; Hagen KB; Kvien TK; Dagfinrud H
    Scand J Rheumatol; 2015; 44(2):118-24. PubMed ID: 25756521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin levels in patients with severe mental disorders.
    Hope S; Melle I; Aukrust P; Agartz I; Lorentzen S; Steen NE; Djurovic S; Ueland T; Andreassen OA
    J Psychiatry Neurosci; 2010 Sep; 35(5):304-10. PubMed ID: 20569643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in psychotic disorders: a population-based study.
    Suvisaari J; Loo BM; Saarni SE; Haukka J; Perälä J; Saarni SI; Viertiö S; Partti K; Lönnqvist J; Jula A
    Psychiatry Res; 2011 Sep; 189(2):305-11. PubMed ID: 21798602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.
    Engh JA; Ueland T; Agartz I; Andreou D; Aukrust P; Boye B; Bøen E; Drange OK; Elvsåshagen T; Hope S; Høegh MC; Joa I; Johnsen E; Kroken RA; Lagerberg TV; Lekva T; Malt UF; Melle I; Morken G; Nærland T; Steen VM; Wedervang-Resell K; Weibell MA; Westlye LT; Djurovic S; Steen NE; Andreassen OA
    Schizophr Bull; 2022 Jan; 48(1):37-46. PubMed ID: 34499169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.
    Hoseth EZ; Ueland T; Dieset I; Birnbaum R; Shin JH; Kleinman JE; Hyde TM; Mørch RH; Hope S; Lekva T; Abraityte AJ; Michelsen AE; Melle I; Westlye LT; Ueland T; Djurovic S; Aukrust P; Weinberger DR; Andreassen OA
    Schizophr Bull; 2017 Jul; 43(4):881-890. PubMed ID: 28049760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
    Wang XS; Williams LA; Krishnan S; Liao Z; Liu P; Mao L; Shi Q; Mobley GM; Woodruff JF; Cleeland CS
    Brain Behav Immun; 2012 Jul; 26(5):699-705. PubMed ID: 22251605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.